Miguel BLANQUER BLANQUER

Sanchez Villalobos M, Salido Fierrez E, Martinez Nieto J, Garcia Garay MC, Beltran Videla A, Perez Oliva AB, Blanquer Blanquer M, Moraleda Jimenez JM. Case Report: alpha-Spectrin Mutation Associated with alphaLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis. Hematol Rep. 2022 Oct 8;14(4):300-304. doi: 10.3390/hematolrep14040043. PubMed PMID: 36278520; PubMed Central PMCID: PMC9589974.

AÑO: 2022

36278520

Guerreiro M, Planelles D, Aguilar-Gallardo C, Lorenzo JI, Montoro J, Sanz J, Balaguer A, Gómez I, Solves P, Pérez A, Blanquer M, Espigado I, Solano C, Piñana JL; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis. HLA. 2021 Mar;97(3):198-213. doi: 10.1111/tan.14179. Epub 2021 Jan 17. PubMed PMID: 33369244.

AÑO: 2021; IF: 8.762

33369244

Gómez García LM, Escudero A, Mestre C, Fuster Soler JL, Martínez AP, Vagace Valero JM, Vela M, Ruz B, Navarro A, Fernández L, Fernández A, Leivas A, Martínez-López J, Ferreras C, De Paz R, Blanquer M, Galán V, González B, Corral D, Sisinni L, Mirones I, Balas A, Vicario JL, Valle P, Borobia AM, Pérez-Martínez A. Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):328-337.e1. doi: 10.1016/j.clml.2021.01.013. Epub 2021 Jan 25. PubMed PMID: 33610500.

AÑO: 2021; IF: 2.822

33610500

Minguela A, Vasco-Mogorrón MA, Campillo JA, Cabañas V, Remigia MJ, Berenguer M, García-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramírez MF, Martínez-Hernández MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.

AÑO: 2021; IF: 5.942

34659897

Bernal, D. G.; Carpes-Ruiz, M.; Martinez, C.; Garcia-Guillen, A.; Blanquer, M.; Garcia-Hernandez, A.; Alguero, M.; Sackstein, R.; Moraleda, J.. MESENCHYMAL STEM CELL IMMUNOREGULATORY EFFECTS ARE BOOSTED BY CD44 LIGATION. CYTOTHERAPY. 2021; 23(5):S129-S130.

AÑO: 2021; IF: 6.196